PsyPost
  • Mental Health
  • Social Psychology
  • Cognitive Science
  • Neuroscience
  • About
No Result
View All Result
Join
My Account
PsyPost
No Result
View All Result
Home Exclusive Psychopharmacology Psychedelic Drugs

New study explores the link between mystical psychedelic trips and a reduced fear of dying

by Bianca Setionago
May 11, 2026
Reading Time: 3 mins read
Share on TwitterShare on Facebook

A new study published in the Journal of Psychedelic Studies has found that people who have had a meaningful psychedelic experience report a significantly reduced fear of death, alongside heightened feelings of connection to themselves, others, and the world around them. Furthermore, the degree of connection closely tracks the degree of relief from death-related fear.

Researchers have long argued that anxiety about dying sits at the root of a surprisingly wide range of psychological struggles, from depression to broader existential distress. Studies have observed that psychedelic experiences—first noted in terminally ill patients in the mid-20th century and later confirmed in modern controlled research—can drastically reduce this fear, though the mechanisms behind why this happens remain unclear.

One leading explanation is increased connectedness: a heightened sense of relationship to oneself, others, and the wider world. Because psychedelics reliably enhance these feelings, researchers sought to investigate whether greater connectedness might be one of the specific pathways through which psychedelics reduce the fear of death.

Led by Noah N. Barr at the University of Wollongong in Australia, the team recruited 106 adults (59 male, 44 female, 2 non-binary; average age 31 years) who had undergone a personally meaningful psychedelic experience using a classical substance. Psilocybin (the active compound in “magic mushrooms”) was the most common, though LSD, ayahuasca, DMT, and mescaline were also represented.

Using an anonymous online survey, participants reflected retrospectively on the three months before and the three months after their experience. They completed validated questionnaires measuring their fear of death, their tendency to avoid thinking about death, their sense of connectedness (to themselves, to others, and to the wider world/universe), and the intensity of any mystical-type experiences during their psychedelic session.

The results were consistent. Participants reported a significantly lower fear of death and significantly less death avoidance after their psychedelic experience compared to before. At the same time, they reported significantly greater connectedness across all three domains.

Crucially, the study found that these changes moved together. People who gained more in their sense of connection to themselves, to others, and to the world were more likely to have also experienced the greatest reductions in their fear of death. Stronger mystical experiences—characterized by feelings of cosmic unity and transcendence—were similarly associated with greater connectedness and a lower fear of death.

However, the findings became more complex when looking at death avoidance—defined as the tendency to actively keep thoughts of death out of conscious awareness. Increases in connectedness to oneself and to others were linked to lower death avoidance. But an increased connectedness to the world, as well as intense mystical experiences, did not predict lower levels of death avoidance.

Google News Preferences Add PsyPost to your preferred sources

The authors suggest this split points to two very different ways people process death after a trip. Feeling more connected to oneself and loved ones seems to promote genuine existential acceptance, where a person stops avoiding the topic of death and stops fearing it.

Conversely, intense mystical experiences may promote a “defensive shift.” A person who feels cosmically connected to the universe may stop fearing death, but they still actively avoid thinking about it—likely because the drug changed their metaphysical beliefs, allowing them to bypass human mortality by believing they will merge with the cosmos when they die.

“An important unresolved question is whether reductions in death anxiety following a psychedelic experience arise through defensive denialistic bypassing or through acceptance and integration of mortality,” Barr and colleagues concluded.

There are significant limitations to keep in mind. Chiefly, the study’s retrospective design—asking participants to recall and compare their mental states from months or years prior—is inherently vulnerable to recall bias, selective memory, and the tendency for a person to unconsciously exaggerate how bad they felt before a life-changing event to make the transformation seem more profound.

The study, “Exploring associations between connectedness and death anxiety following a psychedelic experience,” was authored by Noah N. Barr, Briony Larance, Matthew J. Schweickle, and Sam G. Moreton.

RELATED

Little-known psychedelic drug reduces motivation to take heroin in rats, study finds
Psychedelic Drugs

Are the benefits of psychedelics exaggerated? A new study highlights the problem of selection bias

May 12, 2026
Childhood ADHD traits linked to midlife distress, with societal exclusion playing a major role
Psychedelic Drugs

Real world outcomes support the benefits of psychedelic therapy for severe depression

May 9, 2026
Study finds microdosing LSD is not effective in reducing ADHD symptoms
Depression

LSD microdosing linked to acute mood improvements in adults with depression

May 8, 2026
Novel psychedelic compound 25C-NBF shows rapid antidepressant effects without addictive traits
Psychedelic Drugs

Novel psychedelic compound 25C-NBF shows rapid antidepressant effects without addictive traits

May 6, 2026
Psychedelic science breakthrough: Increased brain entropy from psilocybin predicts lasting psychological insight and well-being
Neuroimaging

Psychedelic science breakthrough: Increased brain entropy from psilocybin predicts lasting psychological insight and well-being

May 5, 2026
New psychology research reveals your face might determine how easily people remember your name
Addiction

A single dose of psilocybin outperforms nicotine patches for quitting smoking

April 27, 2026
New psychology research reveals your face might determine how easily people remember your name
Mental Health

Repeated doses of psilocybin show promise for treating obsessive-compulsive disorder

April 25, 2026
Neuroscience study shows how praise, criticism, and facial attractiveness interact to influence likability
Psilocybin

Brain waves predict the intensity of magic mushroom trips

April 22, 2026

Follow PsyPost

The latest research, however you prefer to read it.

Daily newsletter

One email a day. The newest research, nothing else.

Google News

Get PsyPost stories in your Google News feed.

Add PsyPost to Google News
RSS feed

Use your favorite reader. We also syndicate to Apple News.

Copy RSS URL
Social media
Support independent science journalism

Ad-free reading, full archives, and weekly deep dives for members.

Become a member

Trending

  • Brain scans identify the neural network that traps anxious people in cycles of self-blame
  • Brooding identified as a major driver of bedtime procrastination, alongside physical markers of stress
  • Scientists challenge The Body Keeps the Score with a new predictive model of trauma
  • Eating at least five eggs a week is associated with a 27 percent lower risk of Alzheimer’s
  • Brain scans reveal how people with autistic traits connect differently

Science of Money

  • The Goldilocks zone of sales pressure: Why a little urgency helps and too much hurts
  • What women really want from “girl power” ads: Six ingredients that make femvertising work
  • The seductive allure of neuroscience: Why brain talk feels so satisfying, even when it explains nothing
  • When two heads aren’t better than one: What research reveals about human-AI teamwork in marketing
  • How your personality may shape whether you pick value or growth stocks

PsyPost is a psychology and neuroscience news website dedicated to reporting the latest research on human behavior, cognition, and society. (READ MORE...)

  • Mental Health
  • Neuroimaging
  • Personality Psychology
  • Social Psychology
  • Artificial Intelligence
  • Cognitive Science
  • Psychopharmacology
  • Contact us
  • Disclaimer
  • Privacy policy
  • Terms and conditions
  • Do not sell my personal information

(c) PsyPost Media Inc

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist

Subscribe
  • My Account
  • Cognitive Science Research
  • Mental Health Research
  • Social Psychology Research
  • Drug Research
  • Relationship Research
  • About PsyPost
  • Contact
  • Privacy Policy

(c) PsyPost Media Inc